Dr. Nass received his Bachelor degrees in Biology and Chemistry at North Carolina State University, and his Ph. D in Cellular and Molecular Physiology in 1998. His graduate studies identified and characterized the founding member of the intracellular Na+/H+ exchangers. Dr. Nass pursued his post-doctoral studies at Vanderbilt University where he developed the first C. elegans toxicant and genetic models for Parkinson’s disease. In 2003 Dr. Nass accepted an Assistant Professor position at Vanderbilt University Medical Center where his laboratory developed novel in vivo pharmaco- and toxicogenomic models to explore the molecular basis of Parkinson’s disease and environment-associated dopamine (DA) neuron degeneration. In 2007, Dr. Nass accepted his current position as Associate Professor of Pharmacology and Toxicology at Indiana University School of Medicine where his laboratory continues to investigate the molecular basis of DA neuron vulnerability, neurodegeneration, and Parkinson’s disease, as well as the role that environmental compounds may contribute to neuronal pathogenesis. The Nass laboratory is also exploiting the utilitiy of C. elegans genetics in combination with inductively coupled plasma mass spectrometry (ICP-MS) and high-performance liquid chromatography (HPLC) to develop novel methods and technologies to rapidly identify and characterize ion-associated membrane transport proteins and stress-induced pathways. Dr. Nass’s laboratory has been funded by both public and private agencies including the National Institute of Environmental Health, Environmental Protection Agency, Michael J. Fox Foundation, Department of Defense Manganese Health Research Program, and the Pharmaceutical Research and Manufactuers of America Foundation. He has also received grant support and consulted for pharmaceutical and biotechnology companies.
Biography Updated on 13 August 2012